广药白云山成南京医药第二大股东,截至2024年,在药品流通行业批发、零售企业百强榜单上,广州医药排名第六,南京医药位列第七。大鱼吃小鱼之后,医药流通企业进入一方诸侯之间的合纵连横阶段。此前,重药控股加入通用技术集团后,重庆医药-中国医药联合体成为仅次于中国医药、上海医药、华润医药、九州通医药的第五级。根据Wind数据,2025年全国医药流通市场前十大企业市占率达82%。广药开始加强资本运作9月29...
Source Link广药白云山成南京医药第二大股东,截至2024年,在药品流通行业批发、零售企业百强榜单上,广州医药排名第六,南京医药位列第七。大鱼吃小鱼之后,医药流通企业进入一方诸侯之间的合纵连横阶段。此前,重药控股加入通用技术集团后,重庆医药-中国医药联合体成为仅次于中国医药、上海医药、华润医药、九州通医药的第五级。根据Wind数据,2025年全国医药流通市场前十大企业市占率达82%。广药开始加强资本运作9月29...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.